
Caitlin Wright
Articles
-
Dec 2, 2024 |
insightplus.mja.com.au | Caitlin Wright
A recent study has found that 70% of Australians diagnosed with major depressive disorder are not receiving minimally adequate treatment. The research, published in The Lancet Psychiatry, analysed data from 204 countries and territories to assess global access to mental health care.
-
Oct 28, 2024 |
insightplus.mja.com.au | Caitlin Wright
Expanded access to respiratory syncytial virus vaccines will cover all Australian babies. This year has seen surging rates of respiratory syncytial virus (RSV), particularly in infants. However, with the recent announcement of expanded vaccine access for pregnant women and monoclonal antibody for babies, experts are hopeful that there will be a vast reduction of RSV hospitalisations next year.
-
Oct 28, 2024 |
insightplus.mja.com.au | Caitlin Wright
Parkinson’s disease neurologists and advocates are urging the Australian Pesticides and Veterinary Medicine Authority (APVMA) to ban the common herbicide paraquat, citing compelling evidence linking its use to the development of Parkinson’s disease. Paraquat is a common, non-selective herbicide that is registered for weed control in a range of agricultural situations. It is the active ingredient in 141 registered products and is a Schedule 7 poison, so only licensed people can buy it.
-
Oct 27, 2024 |
insightplus.mja.com.au | Caitlin Wright
A program that aims to fast-track international medical graduates into rural Australian placements is facing criticism for lacking detail and safeguards. GP and rural health colleges have raised concerns over the readiness of the Australian Health Practitioner Regulation Agency’s (AHPRA) new fast-track pathway for rural doctors. The expedited program launched on 21 October 2024 and aims to increase the number of GPs to address critical health shortages.
-
Oct 13, 2024 |
insightplus.mja.com.au | Caitlin Wright
Navigating the complexities of ADHD treatment just got a little easier for clinicians, with the release of a new evidence-based prescribing guide. Launched by the Australasian ADHD Professionals Association (AADPA), this first of its kind ADHD prescribing guide for Australian healthcare professionals is a living document. It will be updated as necessary to reflect the latest evidence and best practice in the field of attention-deficit/hyperactivity disorder (ADHD).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →